TRIM17 is upregulated in cisplatin-resistant lung cancer tissues and cells and reduces cisplatin sensitivity of lung cancer cells by promoting ubiquitination and degradation of RBM38 protein [18]. This evidence concerns the gene TRIM17 and lung carcinoma.